What is 2nd Generation GcMAF?
Second generation Gc-MAF is produced using a new Patent Pending process which was developed in Japan by Saisei Mirai in collaboration with researchers from the University of Tokushima who have been studying GcMAF for over 18 years.
Our GcMAF is made in our sterile cell processing facility using this new and improved 2nd generation method which is 10-20 times more concentrated and is more active and stable than other GcMAF that is currently available.
What diseases can benefit from GcMAF therapy?
Gc-MAF macrophage activation therapy is indicated in the treatment of any diseases where there is immune disfunction or where the immune system is compromised, such as:
Cancer, Autoimmune diseases, Epstein-Barr Virus (EBV), Hepatitis B virus (HCV), Herpes Simplex virus (HSV), Cystitis, Hepatitis C virus (HBV), Tuberculosis, Urinary tract infection (UTI), Autism, Pneumonia infection, Endometriosis, Chronic Fatigue Syndrome (CFS), Lyme disease, IgA deficiency disorder, Myalgic Encephalomyelitis (ME), Mycobacteria infections, Influenza virus, Multiple sclerosis (MS), Fibromyalgia, Parkinson's disease, Lupus, HIV AIDS.
Are there any side effects with GcMAF?
GcMAF has been clinically demonstrated to be largely free of any side effects in the great majority of patients. Only low grade fever or eczema has been observed in only about 1 out of 100 patients using Second Generation GcMAF, but these were short-term effects that are significantly less than occur with most other immunotherapies. In small numbers of patients local injection site skin reactions occur which can be easily treated with a local non-steroidal anti-inflammatory patch.
Can GcMAF be used with other conventional therapies?
Generally, yes. GcMAF can be safely used with a wide variety of other standard treatments and drugs to improve their effect. We refer to this as multimodality integrative medicine. Some therapies for cancer such as chemotherapy will reduce immune activity which will have some impact on GcMAF, however chemotherapy effectiveness can be increased in combination with GcMAF. Radiation for cancer has less negative impact on the immune system and the cancer killing effects helps macrophages to target the tumors and destroy it.